5 Anti-fibrotic pharmaceutical preparations; pharmaceutical anti-inflammatories; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of respiratory diseases; pharmaceutical preparations for the treatment of liver diseases and disorders